Five Doctors from Shonan Beauty Clinic Present Advanced Clinical Research Findings at "IMCAS Asia 2026
Leading Physicians Share Latest Clinical Insights on a Global Stage During the International Medical Congress in Bangkok
IRVINE, Calif. -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Medical Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that five doctors from Shonan Beauty Clinic and Shonan Beauty Dermatology Clinic, to which the Company provides management support, presented their latest research findings at the international medical congress "IMCAS Asia 2026," held in Bangkok, Thailand, from June 19 to 21, 2026.
International Master Course on Aging Science (IMCAS) is one of the world's largest international medical congresses in the fields of aesthetic dermatology, plastic surgery, cosmetic surgery, and anti-aging medicine. It is highly regarded as a platform where doctors, researchers, and healthcare professionals from Asia and around the world gather to share the latest treatment techniques and clinical insights. Under the theme "Pioneering the next era in dermatology, plastic surgery, and aesthetic medicine," IMCAS Asia 2026 featured active discussions on the latest treatment methods and innovative technologies, alongside international academic exchange.
At the congress, five prominent doctors presented their findings: Dr. Ayano Okuda and Dr. Sho Matsuura from Shonan Beauty Clinic Shinjuku Main Branch; Dr. Kaito Kuzushima, Director of Shonan Beauty Clinic Ginza Branch; Dr. Marie Shirai from Shonan Beauty Clinic Kashiwa Branch; and Dr. Torafumi Yao, Director of Shonan Beauty Dermatology Clinic Sapporo Odori Branch. Based on their extensive clinical experience and research in their respective specialized fields, the doctors shared cutting-edge knowledge and engaged in lively discussions with international participants regarding new treatment approaches and clinical implications in the field of aesthetic healthcare.
As technological innovation continues to accelerate in the field of aesthetic healthcare, the importance of knowledge sharing and academic collaboration, beyond the clinical setting alone, has grown considerably. Meeting the increasingly diverse needs of customers requires not only the adoption of advanced techniques, but also broad perspectives and flexible thinking. SBC Medical remains committed to advancing cutting-edge initiatives through academic presentations and research collaborations, and to upholding the safety, transparency, and enduring value of aesthetic healthcare.
Overview of "IMCAS Asia 2026"
Venue: The Athenee Hotel (Bangkok, Thailand)
Dates: June 19, 2026 – June 21, 2026
Official Website: https://www.imcas.com/en/imcas-asia-2026
Presentation Titles and Speakers (In alphabetical order)
Dr. Kaito Kuzushima (Director, Shonan Beauty Clinic Ginza Branch)
Title: Arm lipo-injection: a novel compression-free solution for upper arm contouring
Dr. Sho Matsuura (Shonan Beauty Clinic Shinjuku Main Branch)
Title: A baseline-adjusted planning index to support efficient fat utilization in autologous breast fat grafting
Dr. Ayano Okuda (Shonan Beauty Clinic Shinjuku Main Branch)
Title: Beyond aesthetic improvement: functional and psychological outcomes following labiaplasty in 100 patients
Dr. Marie Shirai (Shonan Beauty Clinic Kashiwa Branch)
Title: Layer-based and sequential approach to periorbital anti-aging in japanese patients
Dr. Torafumi Yao (Director, Shonan Beauty Dermatology Clinic Sapporo Odori Branch)
Title: Expansion of indications and real-world clinical strategies for REJURAN® products
About the Speakers
The presenting speakers are leading physicians performing advanced clinical treatments within the Shonan Beauty Clinic and Shonan Beauty Dermatology Clinic networks. Backed by SBC Medical’s comprehensive operational and management support, they consistently engage in academic research and international presentations to deliver safe, high-quality, and evidence-based aesthetic healthcare options to customers globally.
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose "Contributing to the well-being of people around the world through medical innovation," SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," "targets" or "hopes" or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk Factors" and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov.
Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp